Ontario Institute for Regenerative Medicine joins forces with Stem Cells Australia

01 March 2019
Stem Cells Australia signed an MOU with the Ontario Institute for Regenerative Medicine. International collaboration is critical to support the translation of stem cell therapies. The Ontario Institute for Regenerative Medicine (OIRM) is pleased to announce a new agreement with Stem Cells Australia.

This is a significant step forward in developing international relationships that will advance the development of stem cell therapies in Ontario and Australia.

“OIRM is pleased to have signed a Memorandum of Understanding (MOU) with Stem Cells Australia, which ensures both our stem cell research communities will benefit from new relationships and information sharing. This agreement will facilitate international collaboration for Ontario’s stem cell research community,” says OIRM President and Scientific Director, Dr. Duncan Stewart.

The agreement will allow both initiatives to benefit from the academic and institutional expertise that each brings to the table and is part of a broader strategy to support international collaboration. This includes sharing best practices in translational research that will accelerate moving stem cell-based technologies into early stage clinical trials and discussing how best to incorporate patient perspectives in research and cell therapy clinical trials design.

Commenting on the agreement, Stem Cells Australia’s Program Leader Professor Melissa Little said, “We have been greatly impressed by the approach OIRM have taken to progress research discoveries and are delighted to have an opportunity to work with them to support research, translation and commercialization of innovative regenerative medicine and stem cell technologies.”

Representatives from OIRM met with Stem Cells Australia and other stakeholders at the 2018 International Society for Stem Cell Research Conference in Melbourne to discuss potential projects and provide information to the Australian initiative as it develops the next stage in its research program. This formal agreement will allow the organizations to begin to develop shared activities and programs to support their ongoing goals.